 |
The Big Screen: How COVID-19 Disrupted and Reshaped Cancer PreventionAuthor: Matthew Zachary Worldwide
The Big Screen: How COVID-19 Disrupted and Reshaped Cancer Prevention is a limited educational series about the past, present, and future of cancer detection and its role in improving treatment and health outcomes. Each episode dives deep into the history and value of screening technology, inequities in who gets screened, the role of the pandemic in disrupting early detection, and how improved access and technological advancements in screening will save more lives.The Big Screen is sponsored in part by Bristol Myers Squibb: Creating a Better Future for People with Cancer. Bristol Myers Squibb is inspired by a single vision transforming patients lives through science. The goal of the companys cancer research is to deliver medicines that offer each patient a better, healthier life and to make cure a possibility. For more information visit https://www.bms.com.The Big Screen was also made possible in part with additional support from Daiichi Sankyo and Merck, and through our nonprofit partnership with Stupid Cancer, making adolescent and young adult cancer suck less since 2007. Learn more at https://stupidcancer.org.OffScrip Health would like to further acknowledge and express our gratitude to the National Cancer Institute and the Centers For Disease Control and Prevention for their contributions to this series. Language: en Genres: Education, Health & Fitness, Medicine Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Screening: The Next Generation
Episode 3
Saturday, 1 January, 2022
Cancer screening has saved countless lives through the early detection of breast, cervical, colorectal, and lung cancer. But there are still so many forms of cancer that slip through the cracks. Now, developments in medical research — such as multi-cancer screening blood tests and genomic tests — are promising to revolutionize cancer diagnostics. In this episode, we talk to experts about the medical tech that is reshaping the field of early detection. Dr. Joseph Mikhael, Professor in the Applied Cancer Research and Drug Discovery Division at the Translational Genomics Research Institute, talks about the importance of multi-cancer early detection tests and genomics in detecting cancers that we don't currently screen for. Dr. Brian Druker, Director of the Knight Cancer Institute at Oregon Health & Science University, talks about his role in spearheading the field of precision-based early cancer detection. And Jody Hoyos, President and Chief Operating Officer of Prevent Cancer Foundation, advocates for the passage of the Medicare Multi-Cancer Early Detection Screening Coverage Act to ensure equitable access to life-saving biotech. The Big Screen is a product of OffScripHealth.To learn more about rescheduling your cancer screening appointments, visit https://www.preventcancer.org/back-on-the-books/.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
